Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Health Affairs (Project Hope)|September 8, 2020
Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost MeasuresAlexander T Sandhu, Jay Bhattacharya, Joyce Lam, et al.
Vaccine|September 14, 2019
Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiariesDeepa P Arya, Maria A Said, Hector S Izurieta, et al.
The Lancet. Infectious Diseases|February 13, 2015
Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysisHector S Izurieta, Nicole Thadani, David K Shay, et al.
Vaccine|September 11, 2021
Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018Keran Moll, Hui-Lee Wong, Kathryn Fingar, et al.
JAMA Health Forum|October 11, 2022
Development of Episode-Based Cost Measures for the US Medicare Merit-based Incentive Payment SystemReena Duseja, Joel Andress, Alexander T Sandhu, et al.
Transfusion|February 22, 2023
Immune globulin usage trends in commercially insured and Medicare populations, 2009-2019Yixin Jiao, Keran Moll, Graça M Dores, et al.
Vaccine|December 10, 2022
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and olderHui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, et al.
Vaccine|February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
Vaccine|November 20, 2022
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020Keran Moll, Bradley Lufkin, Kathryn R Fingar, et al.
Pageof 2